2022
DOI: 10.1021/acs.orglett.2c01166
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Indenone Derivatives by Rh(III)-Catalyzed C–H Functionalization of Sulfoxonium Ylides with 1,3-Diynes

Abstract: The transition-metal-catalyzed C−H functionalization of sulfoxonium ylides with alkynes formally participates in [4 + 2] annulations to deliver the naphthol scaffolds. In contrast, herein we disclose the first Rh(III)-catalyzed C−H activation, followed by redox-neutral [3 + 2] annulation of sulfoxonium ylides with 1,3diynes, which delivers the alkynated indenone derivatives. This protocol features a good functional group tolerance, a broad substrate scope, moderate to excellent yields, and mild reaction cond… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 20 publications
(21 citation statements)
references
References 47 publications
0
21
0
Order By: Relevance
“…Our rationalisation of the observed regioselectivity is based on our previous report 39 and literature precedent. [40][41][42][43][44][45][46] In our earlier work using symmetrical bulky diphenyl-and diphenoxy-1,3-diynes, the major regioisomers obtained each had the alkynyl substituent at the 3-position, ortho to the amide nitrogen and its pendent quinolinyl directing group. The steric bulk of the directing group makes the approach of the diyne for metallacycle formation easier with the bulky substituent furthest from the quinolinyl moiety.…”
Section: Papermentioning
confidence: 99%
See 1 more Smart Citation
“…Our rationalisation of the observed regioselectivity is based on our previous report 39 and literature precedent. [40][41][42][43][44][45][46] In our earlier work using symmetrical bulky diphenyl-and diphenoxy-1,3-diynes, the major regioisomers obtained each had the alkynyl substituent at the 3-position, ortho to the amide nitrogen and its pendent quinolinyl directing group. The steric bulk of the directing group makes the approach of the diyne for metallacycle formation easier with the bulky substituent furthest from the quinolinyl moiety.…”
Section: Papermentioning
confidence: 99%
“…37 After these initial developments, research teams have disclosed a range of interesting examples with symmetrical 1,3-diynes (Scheme 1a). [38][39][40][41][42] Nonetheless, the use of unsymmetrical 1,3-diynes has been limited. This may be due to the inherent possibility of metalloalkynylation through two similar sites, leading to several possible regioisomers (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…The synthetic efficiency of the methodology further demonstrated by the synthesis of diverse synthetic analogues, which are the core structures of many biologically active compounds (Scheme 52). [43] The authors proposed the following catalytic cycle (Scheme 53), which is supported through ESI-HRMS by characterizing all the key intermediates in the catalytic cycle. Coordination of the carbonyl oxygen atom of sulfoxonium…”
Section: R E V I E W T H E C H E M I C a L R E C O R Dmentioning
confidence: 99%
“…The synthetic efficiency of the methodology further demonstrated by the synthesis of diverse synthetic analogues, which are the core structures of many biologically active compounds (Scheme 52). [43] …”
Section: Carbocyclizationsmentioning
confidence: 99%
“…For example, Chatanis group reported a Rh(III)‐catalyzed reaction of sulfoxonium ylides with alkenes to afford indanone derivatives [12a] (Scheme 1a). Subsequently, Yu, [12b] Prabhu [12c] and Cheng [12d] demonstrated the use of sulfoxonium ylides as TDG to synthesize polycyclic compounds in a domino fashion, respectively (Scheme 1b, Scheme 1c, Scheme 1d), etc [12e–h] . Inspired by these elegant pioneering studies and the ubiquity of indanone cores in biologically active compounds, we envisaged the possibility of C−H activation/annulation using sulfoxonium ylides as C4 synthons to access indanone‐fused polycyclic compounds.…”
Section: Introductionmentioning
confidence: 99%